Nature Index officially published the ranking list of nature index in 2021. As a representative enterprise of "omics -driven new drug R&D", Precision Scientific is continuing to occupy the ranking list of the Chinese biomedical industry institution with high-quality scientific research output this year, ranking 5th, rising rapidly from 32nd in 2020.
"Precision Human HRD Assay (Reversible Termination Sequencing)" (Registration No. RPS/1075/2022) and "Precision Human BRCA1/BRCA2 Gene Mutation Detection Kit (Reversible Termination Sequencing)" (Registration No. RPS/133/2022) independently developed by Precision Scientific have passed the EU CE certification and obtained the EU market access qualification.
Nov 2021, Signing ceremony with Roche Diagnostics for strategic partnership in NGS-based CDx research & development.
Mar 2021，Precision Scientific has reached a strategic cooperation agreement with Illumina and became IVD partner, in which both sides will carry out in-depth cooperation in the registration of cancer companion diagnostic products, and try the best to promote the registration and application of cancer companion diagnostic kits in China.